Skip to content
VP
Company

Updated:

VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001003929, and its reported...

Overview

VIA Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001003929, and its reported industry is Biological Products, (No Diagnostic Substances). The retained history contains 12 filings, including 10-K filed on 2011-03-24. Each filing retains its accession, filing date and original SEC document link. This historical evidence does not establish current registration, listing, ownership or financial condition.

Company overview

Legal name
VIA Pharmaceuticals, Inc.
Former names in filing history
CORAUTUS GENETICS INC (2003-02-14 to 2007-06-20); GENSTAR THERAPEUTICS CORP (2000-07-10 to 2002-12-19); UROGEN CORP (1996-08-13 to 2000-02-14)
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
San Francisco, CA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001003929

Recent SEC filings

FormFiledPeriodFiling
10-KFORM 10-K
SC 13G—SC 13G
8-KFORM 8-K
8-KFORM 8-K
10-QFORM 10-Q
8-KFORM 8-K
8-KFORM 8-K
10-Q10-Q
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research VIA Pharmaceuticals, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

VIA Pharmaceuticals, Inc. | San Francisco Company | Altss